CLDN3 and breast carcinoma: Both the MDA-MB-436 and MDA-MB-231 lines belong to the molecular subtype of claudin-low breast cancer characterized by low expression of markers associated with cell–cell interaction such as claudine 3, 4 and 7, occludin or E- cadherin, high expression of mesenchymal EMT markers and stem cell traits.